Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bioscience trends

Showing results (1011-1020 of 1,145) with videos related to

Pageof 115
Sort By:
Bioscience Trends|June 22, 2022
Treatment of biliary tract carcinoma over the last 30 yearsYutaka Midorikawa
Bioscience Trends|June 12, 2022
The preventive effect of loganin on oxidative stress-induced cellular damage in human keratinocyte HaCaT cellsCheol Park, Hyesook Lee, Soojung Jin, et al.
Bioscience Trends|December 17, 2020
Half depletion of Foxp3+ regulatory T cells by diphtheria toxin for long-term study in vivoXuemin Qiu, Wing Ting Leung, Hans-Jürgen Gober, et al.
Bioscience Trends|December 17, 2020
Association of HIV infection with metabolic syndrome among normal or underweight young adults: evidence from the CHART cohortRuizi Shi, Xiaoxiao Chen, Haijiang Lin, et al.
Bioscience Trends|January 4, 2021
Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19?Masashi Ohe, Ken Furuya, Houman Goudarzi
Bioscience Trends|May 27, 2021
Conversion therapy and maintenance therapy for primary hepatocellular carcinomaHongyuan Zhou, Tianqiang Song
Bioscience Trends|May 27, 2021
The multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombusGuoteng Qiu, Kunlin Xie, Zhaoxing Jin, et al.
Bioscience Trends|February 20, 2020
Electrocardiographic abnormalities among people with HIV in Shanghai, ChinaFang Shen, Bowen Zhu, Yingying Ding, et al.
Bioscience Trends|February 6, 2020
Fast time perception is associated with high levels of anxiety in cancer patients prior to starting chemotherapyIvan Shterev Donev, Martina Stoyanova Ivanova, Nikolay Vladimirov Conev
Bioscience Trends|February 6, 2020
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancerMila P Petrova, Mariyana I Eneva, Jeliazko I Arabadjiev, et al.
Pageof 115

Showing results (1011-1020 of 1,145) with videos related to

Sort By:
Pageof 115
Bioscience Trends|June 22, 2022
Treatment of biliary tract carcinoma over the last 30 yearsYutaka Midorikawa
Bioscience Trends|June 12, 2022
The preventive effect of loganin on oxidative stress-induced cellular damage in human keratinocyte HaCaT cellsCheol Park, Hyesook Lee, Soojung Jin, et al.
Bioscience Trends|December 17, 2020
Half depletion of Foxp3+ regulatory T cells by diphtheria toxin for long-term study in vivoXuemin Qiu, Wing Ting Leung, Hans-Jürgen Gober, et al.
Bioscience Trends|December 17, 2020
Association of HIV infection with metabolic syndrome among normal or underweight young adults: evidence from the CHART cohortRuizi Shi, Xiaoxiao Chen, Haijiang Lin, et al.
Bioscience Trends|January 4, 2021
Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19?Masashi Ohe, Ken Furuya, Houman Goudarzi
Bioscience Trends|May 27, 2021
Conversion therapy and maintenance therapy for primary hepatocellular carcinomaHongyuan Zhou, Tianqiang Song
Bioscience Trends|May 27, 2021
The multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombusGuoteng Qiu, Kunlin Xie, Zhaoxing Jin, et al.
Bioscience Trends|February 20, 2020
Electrocardiographic abnormalities among people with HIV in Shanghai, ChinaFang Shen, Bowen Zhu, Yingying Ding, et al.
Bioscience Trends|February 6, 2020
Fast time perception is associated with high levels of anxiety in cancer patients prior to starting chemotherapyIvan Shterev Donev, Martina Stoyanova Ivanova, Nikolay Vladimirov Conev
Bioscience Trends|February 6, 2020
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancerMila P Petrova, Mariyana I Eneva, Jeliazko I Arabadjiev, et al.
Pageof 115